65,437 trials
Microvascular Coronary Dysfunction (MCD)
Primary: Seattle Angina Questionnaire (SAQ) — 68.09; 66.7; 58.4; 51.17 Units on scale
Sarcoma
Primary: Number of Patients With Objective Tumor Response Rate (Complete Response [CR] or Partial Response [PR]) Using RECIST Version 1.0 — 2; 0 participants
Asthma
Primary: Change From Baseline in Asthma Control Questionnaire (ACQ-7) Over 12 Weeks — -0.1; -0.2; -0.1; -0.3 Scores on Scale — p=0.1955
Venous Reflux
Primary: Percentage of Limbs Without Vein Occlusion — 97.6 percentage of limbs
Cirrhosis, Liver
Primary: Mean Change From Baseline in Liver Biopsy Immunohistochemical Marker of Hepatic Stellate Cell (HSC) Activation and Collagen Synthesis at Week 52 — 0.02065; 0.02819…
Allergic Asthma
Primary: Changes in the Peripheral Blood Basophil Response to Crosslinking Anti-IgE Ab — 7.8 Fold change in basophil Syk expression
Breast Cancer
Primary: Agreement of Labeling Between Isosulfan Blue (IS-BLUE) and Indocyanine Green (IC-GREEN) — 8 Participants
Kidney Failure, Chronic
Primary: C0 (ng/mL) — 1.45; 6.2; 1.25; 6.5 ng/mL
Pulmonary Arterial Hypertension
Primary: Treatment Emergent Adverse Events (AEs) up to 7 Days After Permanent Study Drug Discontinuation — 29; 26 Participants
Pain Threshold · Mood
Primary: Pain Tolerance — 6.1; 2.8; 4.9; 1.5 seconds
Glioblastoma Multiforme · Brain Metastases
Primary: Tumor to Background Ratios (TBR) Post-imaging for All Lesions With PET Uptake — 8.25; 8.75 Ratio of PET SUV
Hepatitis C, Chronic
Primary: Number of Participant Achieving Rapid Virological Response (RVR) at Day 28, Nominal Analysis — 3; 3; 8; 1 Participants
Leg Ulcers
Primary: Percentage Change of the Leg Ulcer Area Measured by Planimetry at Week 6 Compared to the Ulcer Area at Baseline — -41.5; -35.0 Percentage change
Cocaine Dependence
Primary: Cocaine Intoxication — 59; 51; 45; 44 units on a scale
Schizophrenia · Schizoaffective Disorder · Schizophreniform Disorder
Primary: Hamilton Depression Rating Scale (Ham-D) — 22.9; 20.6; 19.4; 18.6 units on a scale